Safety and Efficacy of Ubrogepant in Participants With Moderate to High Cardiovascular Risk

被引：0
|
作者：
Severt, Lawrence [1 ]
Silberstein, Stephen D. [2 ]
Blumenfeld, Andrew M. [3 ]
Lipton, Richard B. [4 ]
Lu, Kaifeng [1 ]
Yu, Sung Yun [1 ]
Hutchinson, Susan [5 ]
机构：
[1] Allergan Plc, Dublin, Ireland
[2] Thomas Jefferson Univ Hosp, Philadelphia, PA 19107 USA
[3] Headache Ctr Southern Calif, Irvine, CA USA
[4] Albert Einstein Coll Med, Bronx, NY 10467 USA
[5] Orange Cty Migraine & Headache Ctr, Irvine, CA USA
来源：
NEUROLOGY | 2020年 / 94卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
107
引用
收藏
页数：4
相关论文
共 50 条
  • [31] Romosozumab for the treatment of osteoporosis in women: Efficacy, safety, and cardiovascular risk
    Lim, Sian Yik
    WOMENS HEALTH, 2022, 18
  • [32] Denosumab Safety and Efficacy Among Participants in the FREEDOM Extension Study With Mild to Moderate Chronic Kidney Disease
    Broadwell, Aaron
    Chines, Arkadi
    Ebeling, Peter R.
    Franek, Edward
    Huang, Shuang
    Smith, Shawna
    Kendler, David
    Messina, Osvaldo
    Miller, Paul D.
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2021, 106 (02): : 397 - 409
  • [33] Efficacy and safety of ubrogepant for migraine: a meta-analysis of randomized controlled studies
    Wu, Shu-Zhi
    Chen, Linglong
    INTERNATIONAL JOURNAL OF NEUROSCIENCE, 2024, 134 (02) : 124 - 130
  • [34] Efficacy and safety of bemiparin in high risk pregnancy
    Rios Fernandez, R.
    Callejas-Rubio, J. L.
    Vizcaino, A.
    Quezada, M. S.
    Fernandez, A.
    Cruz, M.
    Ortego Centeno, N.
    SWISS MEDICAL WEEKLY, 2009, 139 (31-32) : 14S - 14S
  • [35] Safety and efficacy of a cardiovascular polypill in people at high and very high risk without a previous cardiovascular event: the international VULCANO randomised clinical trial
    José M. Mostaza
    Carmen Suárez-Fernández
    Juan Cosín-Sales
    Ricardo Gómez-Huelgas
    Carlos Brotons
    Francisco Pestana Araujo
    Gabriela Borrayo
    Emilio Ruiz
    BMC Cardiovascular Disorders, 22
  • [36] Safety and efficacy of a cardiovascular polypill in people at high and very high risk without a previous cardiovascular event: the international VULCANO randomised clinical trial
    Mostaza, Jose M.
    Suarez-Fernandez, Carmen
    Cosin-Sales, Juan
    Gomez-Huelgas, Ricardo
    Brotons, Carlos
    Pestana Araujo, Francisco
    Borrayo, Gabriela
    Ruiz, Emilio
    BMC CARDIOVASCULAR DISORDERS, 2022, 22 (01)
  • [37] Efficacy and Safety of Proton-Pump Inhibitors in High-Risk Cardiovascular Subsets of the COGENT Trial
    Vaduganathan, Muthiah
    Cannon, Christopher P.
    Cryer, Byron L.
    Liu, Yuyin
    Hsieh, Wen-Hua
    Doros, Gheorghe
    Cohen, Marc
    Lanas, Angel
    Schnitzer, Thomas J.
    Shook, Thomas L.
    Lapuerta, Pablo
    Goldsmith, Mark A.
    Laine, Loren
    Bhatt, Deepak L.
    AMERICAN JOURNAL OF MEDICINE, 2016, 129 (09): : 1002 - 1005
  • [38] Short-term efficacy and safety of high-intensity statin therapy in patients with very high cardiovascular risk
    Vorobyeva, M. Maria
    Doronina, A.
    Lobzhanidze, T.
    Villevalde, S.
    Kobalava, Z.
    EUROPEAN JOURNAL OF HEART FAILURE, 2015, 17 : 87 - 87
  • [39] Safety and Tolerability of Ubrogepant Following Intermittent, High-Frequency Dosing
    Goadsby, P. J.
    Tepper, S. J.
    Watkins, P.
    Ayele, G.
    Miceli, R.
    Severt, L.
    Finnegan, M.
    Szegedi, A.
    Trugman, J. M.
    Jakate, A.
    HEADACHE, 2019, 59 : 80 - 81
  • [40] Randomized Phase II Study of the Safety and Efficacy of Semorinemab in Participants With Mild-to-Moderate Alzheimer Disease: Lauriet
    Monteiro, Cecilia
    Toth, Balazs
    Brunstein, Flavia
    Bobbala, Ashwini
    Datta, Seema
    Ceniceros, Ryan
    Sanabria Bohorquez, Sandra M.
    Anania, Veronica G.
    Wildsmith, Kristin R.
    Schauer, Stephen P.
    Lee, Julie
    Dolton, Michael J.
    Ramakrishnan, Vidya
    Abramzon, Daniel
    Teng, Edmond
    NEUROLOGY, 2023, 101 (14) : E1391 - E1401
12345